The Catheter-Related Bloodstream Infections (CRBSIs) market is expected to reach US$ 3 billion in 2030 with a CAGR of 7.1%. Catheter-related bloodstream infections (CRBSIs) are serious hospital-acquired infections that occur when microbes travel down intravenous catheters like central lines and urinary catheters and enter the bloodstream.
The rising prevalence of chronic diseases requiring catheterization such as diabetes, cancer, kidney failure is fueling the demand for catheters, which is driving the CRBSI market growth. Advancements in technology such as novel antimicrobial catheter materials and coatings, real-time tracking devices, and ultrasound-guided insertion are also propelling the market growth. Further, the introduction of stringent guidelines by healthcare agencies for infection control and prevention is compelling healthcare facilities to adopt advanced CRBSI solutions.
The increasing healthcare expenditure on improving hospital infrastructure and the growing focus on infection control are presenting growth opportunities for CRBSI market players. Developing regions also offer significant expansion potential owing to the large underpenetrated patient pool and improving healthcare access. Additionally, the integration of technologies like sensors, machine learning, and robotics in catheter systems to lower infection risks provides growth avenues. However, the premium pricing of advanced catheters and reimbursement challenges pose restraints.
North America is expected to dominate the global CRBSI market owing to high incidence rates, established healthcare infrastructure, presence of key players like BD, Teleflex, and ICU Medical, rising healthcare spending, and stringent regulations regarding hospital-acquired infections. Europe also accounts for a significant share driven by the rising prevalence of target diseases, elderly population, and policies for infection surveillance. Asia Pacific offers lucrative growth prospects attributable to expanding patient base, medical tourism, healthcare reforms, and advancing hospital infrastructure.
Some key companies operating in the global CRBSI market include Becton Dickinson, 3M, Teleflex, B. Braun Melsungen, Baxter International, ICU Medical, Merit Medical, Edwards Lifesciences, Utah Medical Products, and Argon Medical Devices, among others. These players are focused on developing novel catheter materials, coatings, and securing devices to curb infection risks and expand market share.
- The rising prevalence of chronic diseases like diabetes and cancer requiring catheterization for fluid and medication administration, drainage, dialysis, and other purposes is driving the demand for catheters, in turn fueling the CRBSI market growth.
- Advancements in technology such as novel antimicrobial coatings, surface modifications, noble metal biomaterials, and integration of sensors for real-time tracking are lowering catheter-associated infection risks and supporting market growth.
- There is increasing R&D focus on developing alternative antimicrobial solutions including antimicrobial peptides, nitric oxide coatings, and bacteriophages to curb antimicrobial resistance.
- The shift towards single-use sterile pre-treated catheters and accessories with integrated antiseptic coatings is rising to minimize infections.
- Expanding patient base and improving healthcare access in developing regions offer significant growth opportunities for CRBSI market players.
Key Report Insights:
- North America accounted for over 38% of the global CRBSI market share in 2023. Prominent players in North America include BD, 3M, Teleflex, ICU Medical, etc. Favorable reimbursements, established healthcare infrastructure, and high awareness are supporting the growth.
- Europe accounted for 27% market share in 2023. Key companies in Europe are B. Braun Melsungen, Smith Medical, Vygon Group. Growth is driven by rising incidence of chronic diseases, geriatric population, and stringent healthcare regulations.
- Some of the prominent companies in the global CRBSI market are Becton Dickinson, 3M, Teleflex, B. Braun Melsungen, Baxter International, ICU Medical, Merit Medical Systems, Utah Medical Products, and Edwards Lifesciences.
Catheter-Related Bloodstream Infections (CRBSIs) Market Segmentation:
By Product Type
- Central Venous Catheters
- Peripheral Venous Catheters
- Urinary Catheters
- Arterial Catheters
- Chest Drainage Tubes
- Others (Epidural, Hemodialysis)
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Dialysis Centers
- Others (Homecare, Research)
- Others (Rubber, metal alloy)
By Coating Type
- Antimicrobial Coated
- Hydrophilic Coated
- Drug Coated
- Others (Antithrombogenic, Surface Treated)
- Anchoring Devices
- Adhesive Anchor Devices
- Others (Surgical Tape, Staples)
- North America
- Asia Pacific
- Rest of the World
“Catheter-related bloodstream infections (CRBSIs) refer to serious infections that occur when bacteria travel down intravenous catheters like central lines and urinary catheters and enter the bloodstream. CRBSIs are a major concern in healthcare settings owing to associated morbidity, mortality, and costs. The CRBSI market involves products used for preventing microbial colonization of catheters such as antimicrobial catheters, securement devices, needleless connectors, etc.”